
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
NewGen's 6% Stake in K25.ai Now Valued at US$6 Million Company will Leverage Expertise of K25.ai's Andy Cheung to Develop Digital Asset Treasury Strategy BANGKOK, June 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced it has exercised its top-up option to acquire an additional 4% equity interest in AI-native livestreaming prediction market platform K25.ai, raising its total holding to 6%. The additional US$4 million investment, which supplements an initial US$2 million investment announced in May 2026, is split evenly between cash and newly issued NewGen Class A ordinary shares.

NewGen executes Share Purchase Agreement to acquire an initial 2% equity interest in K25.ai, with the right to invest up to 10% in total NewGen also executes Exclusive Agency Agreement with K25.ai, appointing NewGen as K25.ai's exclusive agency partner for selected permitted APAC markets, creating a potential asset-light commercial growth channel According to media reports citing Bernstein research, prediction market volumes could reach approximately US$1 trillion by 2030 as the category evolves into broader information markets across sports, crypto, politics, macroeconomic and event-driven contracts APAC market tailwinds across mobile, digital economy, gaming, esports, live-streaming, social video and AI-enabled engagement provide a compelling foundation for localized prediction and information-market platforms BANGKOK, May 28, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today announced that it has executed a Share Purchase Agreement and an Exclusive Agency Agreement with K25.ai, an APAC-focused AI-powered live-streaming and watch-to-predict platform led by technology veteran Andy Cheung. Under the Share Purchase Agreement, NewGen will acquire an initial 2% equity interest in K25.ai for US$2 million, implying a US$100 million valuation, with the right to increase its ownership to up to 10% on the same valuation terms.

Nasdaq-listed NIVF has made an initial US$2 million strategic investment in K25.ai (with an option for up to US$10M). K25.ai co-founders will join NIVF's board to support deeper strategic alignment, as the partnership accelerates K25.ai's AI-native watch-to-predict platform and APAC expansion.

BANGKOK and SINGAPORE, May 21, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGenIVF” or the “Company”), a technology-driven, diversified growth company, today announced that it has entered into a strategic investment agreement with K25.ai, an APAC-focused AI-powered watch-to-predict platform led by Mr. Andy Cheung, former Chief Operating Officer of OKX and former Chief Executive Officer of Groupon Hong Kong.

NewGen records strong balance sheet with total assets of US$32.7 million Net profit attributable to shareholders of the Company of US$9.9 million BANGKOK, May 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today outlined several highlights of its fiscal year 2025 results and the steady progress of its continued strategic transformation. More information on NewGen's results can be found in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2025, (the “2025 Annual Report”) which was filed with the U.S. Securities and Exchange Commission (the “SEC”) in April 2026.

BrightSpring Health Services (NASDAQ: BTSG - Get Free Report) and NewGenIvf Group (NASDAQ: NIVF - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations. Risk and Volatility BrightSpring Health Services has

NewGenIvf Group Limited (NASDAQ: NIVF - Get Free Report) was the target of a significant increase in short interest in February. As of February 27th, there was short interest totaling 19,795 shares, an increase of 80.4% from the February 12th total of 10,974 shares. Currently, 3.0% of the company's stock are short sold. Based on an
